In this randomised , double-blind , placebo-controlled , parallel-group study , we enrolled patients aged 18-55 years with clinically isolated syndrome ( defined as a neurological event consistent with demyelination , starting within 90 days of randomisation , and two or more T2-weighted MRI lesions 3 mm in diameter ) from 112 centres ( mostly hospitals ) in 20 countries .